NEW YORK, Nov 6 (Reuters) - Abbott Laboratories (ABT.N: Quote, Profile, Research) on Tuesday sold $3.5 billion of debt in three parts, said a source familiar with the deal. The issue included $1 billion in five-year notes priced to yield 1.17 percentage points over U.S. Treasuries; $1.5 billion in 10-year notes priced to yield 1.27 percentage points over Treasuries; and $1 billion in 30-year bonds yielding 1.50 percentage points over Treasuries.
